Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Liver transplantation for non-alcoholic steatohepatitis in Europe: Where do we stand?

Durand F, Pavesi M, Cheung R.

J Hepatol 2019, 71(2): 240–242

DOI: 10.1016/j.jhep.2019.05.018

Combination of CCl(4) with alcoholic and metabolic injuries mimics human liver fibrosis

Brol MJ, Rösch F, Schierwagen R, Magdaleno F, Uschner FE, Manekeller S, Queck A, Schwarzkopf K, Odenthal M, Drebber U, Thiele M, Lingohr P, Plamper A, Kristiansen G, Lotersztajn S, Krag A, Klein S, Rheinwalt KP, Trebicka J.

Am J Physiol Gastrointest Liver Physiol 2019, 317(2): G182–G194

DOI: 10.1152/ajpgi.00361.2018

Circulating levels of PRO-C3 reflect liver fibrosis and liver function in HIV positive patients receiving modern cART

Dold L, Nielsen MJ, Praktiknjo M, Schwarze-Zander C, Boesecke C, Schierwagen R, Mohr R, Wasmuth JC, Jansen C, Bischoff J, Rockstroh JK, Karsdal MA, Spengler U, Trebicka J, Leeming DJ.

PLoS One 2019, 14(7): e0219526

DOI: 10.1371/journal.pone.0219526

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Runken MC, Caraceni P, Fernandez J, Zipprich A, Carlton R, Bunke M.

Health Econ Rev 2019, 9(1): 22

DOI: 10.1186/s13561-019-0237-7

Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis

Fernández J, Clària J, Amorós A, Aguilar F, Castro M, Casulleras M, Acevedo J, Duran-Güell M, Nuñez L, Costa M, Torres M, Horrillo R, Ruiz-Del-Árbol L, Villanueva C, Prado V, Arteaga M, Trebicka J, Angeli P, Merli M, Alessandria C, Aagaard NK, Soriano G, Durand F, Gerbes A, Gustot T, Welzel TM, Salerno F, Bañares R, Vargas V, Albillos A, Silva A, Morales-Ruiz M, Carlos García-Pagán J, Pavesi M, Jalan R, Bernardi M, Moreau R, Páez A, Arroyo V.

Gastroenterology 2019, 157(1): 149–162

DOI: 10.1053/j.gastro.2019.03.021

Leukocytes from obese individuals exhibit an impaired SPM signature

López-Vicario C, Titos E, Walker ME, Alcaraz-Quiles J, Casulleras M, Durán-Güell M, Flores-Costa R, Pérez-Romero N, Forné M, Dalli J, Clària J.

FASEB J 2019, 33(6): 7072–7083

DOI: 10.1096/fj.201802587R

Potential value of urinary amatoxin quantification in patients with hepatotoxic mushroom poisoning

Escoda O, Reverter E, To-Figueras J, Casals G, Fernández J, Nogué S.

Liver Int 2019, 39(6): 1128–1135

DOI: 10.1111/liv.14028

Review of defective NADPH oxidase activity and myeloperoxidase release in neutrophils from patients with cirrhosis

Moreau R, Périanin A, Arroyo V.

Front Immunol 2019, 10: 1044

DOI: 10.3389/fimmu.2019.01044

Adverse events and acute chronic liver failure in patients with cirrhosis undergoing endoscopic retrograde cholangiopancreatography: A multicenter matched-cohort study

Leal C, Prado V, Colan J, Chavez-Rivera K, Sendino O, Blasi A, Roura P, Juanola A, Rodriguez de Miguel C, Pavesi M, Gomez C, Guarner C, Guarner-Argente C, Fernández J, Cardenas A.

Am J Gastroenterol 2019, 114(1): 89–97

DOI: 10.1038/s41395-018-0218-1

Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis

Lehmann J, Praktiknjo M, Nielsen MJ, Schierwagen R, Meyer C, Thomas D, Violi F, Strassburg CP, Bendtsen F, Møller S, Krag A, Karsdal MA, Leeming DJ, Trebicka J.

Liver Int 2019, 39(5): 885–893

DOI: 10.1111/liv.14070

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024